Karmela Kim Chan, MD
RheumatologyAbout Dr. Chan
Dr. Chan graduated from medical school in the Philippines fully convinced that she wanted to become a rheumatologist. She worked towards that goal, finishing her internal medicine residency at the University of Connecticut and her rheumatology fellowship at the University of Massachusetts.
Before moving to New York City, she spent seven years in private practice in Rhode Island and was Clinical Assistant Professor of Medicine at Brown University, where she saw a broad range of patients with rheumatic conditions. She has a particular clinical interest in inflammatory arthritis, inflammatory eye disease, and SAPHO syndrome. Her research interest is in the rheumatic complications of the immunotherapy of cancer.
Departments
Specialized Centers
Inflammatory Arthritis Center
Integrative Rheumatology and Orthopedics Center
Patient Stories
Insurance
Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may have coverage subject to the availability of 'out-of-network' benefits.
Credentials
Appointments
Assistant Attending Physician, Hospital for Special Surgery
Assistant Attending Physician, Memorial Sloan Kettering Cancer Center
Assistant Professor of Medicine, Weill Cornell Medical College
Education
University of Santo Tomas in Manila, Philippines
Internship
University of Connecticut
Residency
University of Connecticut
Fellowship
University of Massachusetts
Certification
Rheumatology
Internal Medicine
Awards
Top Doctor, Rhode Island Magazine 2015-2016
State Licensure
Languages
English, Tagalog
Publications
Selected Publications
Chan K K, Bass A R. Autoimmune complications of immunotherapy: pathophysiology and management BMJ 2020; 369 :m736 doi:10.1136/bmj.m736
Chan KK, Magro C, Shoushtari A, et al. Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature. Oncologist. 2020;25(2):140-149. doi:10.1634/theoncologist.2019-0508
Reid P, Liew DF, Akruwala R, Bass AR, Chan KK. Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study. J Immunother Cancer. 2021;9(9):e003260. doi:10.1136/jitc-2021-003260
Chan, K.K., Tirpack, A., Vitone, G., Benson, C., Nguyen, J., Ghosh, N., Jannat-Khah, D., Bykerk, V. and Bass, A.R. (2020), Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry. ACR Open Rheumatology, 2: 595-604. https://doi.org/10.1002/acr2.11181
Ghosh, Nilasha MD*,†; Tiongson, Michael D. BA‡; Stewart, Carolyn BA†; Chan, Karmela K. MD*,†; Jivanelli, Bridget MLIS*; Cappelli, Laura MD§; Bass, Anne R. MD*,† Checkpoint Inhibitor–Associated Arthritis, JCR: Journal of Clinical Rheumatology: April 25, 2020 - Volume - Issue -
doi: 10.1097/RHU.0000000000001370
Research
Industry Relationships
Industry Relationships
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of December 22, 2020, Dr. Chan reported no relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.